{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:43:44Z","timestamp":1792579424165,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University Hospital of Guadeloupe","award":["APL 2018"],"award-info":[{"award-number":["APL 2018"]}]},{"name":"French Ministry of Health","award":["Inter-regional Hospital Clinical Research Program 2011-A01259-32"],"award-info":[{"award-number":["Inter-regional Hospital Clinical Research Program 2011-A01259-32"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00702-026-03229-6","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:04:03Z","timestamp":1788332643000},"page":"2661-2670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher serum uric acid associates with better cognitive performance and survival in Caribbean parkinsonism"],"prefix":"10.1007","volume":"133","author":[{"given":"Tanicia","family":"Mameri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6083-3787","authenticated-orcid":false,"given":"Regine","family":"Edragas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Chavonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-4281","authenticated-orcid":false,"given":"Benoit","family":"Tressieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4948-2986","authenticated-orcid":false,"given":"Loic","family":"Dragin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5575-1424","authenticated-orcid":false,"given":"Angela","family":"Lackmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pelonde-Erimee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2248-8989","authenticated-orcid":false,"given":"Stanie","family":"Gaete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7143-693X","authenticated-orcid":false,"given":"Regine","family":"Hierso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-7376","authenticated-orcid":false,"given":"Pierre","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-3459","authenticated-orcid":false,"given":"Emmanuel","family":"Roze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5607-3119","authenticated-orcid":false,"given":"Patrick Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-8674","authenticated-orcid":false,"given":"Annie","family":"Lannuzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"3229_CR1","doi-asserted-by":"publisher","unstructured":"Ames BN et al (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78(11):6858\u20136862. Available at: https:\/\/doi.org\/10.1073\/pnas.78.11.6858","DOI":"10.1073\/pnas.78.11.6858"},{"key":"3229_CR2","doi-asserted-by":"publisher","unstructured":"Andretto de B et al (2025) Uric acid, the end-product of purine metabolism, mitigates tau-related abnormalities: comparison with DOT, a non-antibiotic oxytetracycline derivative. Biomolecules 15(7):941. Available at: https:\/\/doi.org\/10.3390\/biom15070941","DOI":"10.3390\/biom15070941"},{"issue":"7","key":"3229_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2007.11.001","volume":"14","author":"T Annanmaki","year":"2008","unstructured":"Annanmaki T et al (2008) Uric acid associates with cognition in Parkinson\u2019s disease. Parkinson Relat Disord 14(7):576\u2013578. Available at: https:\/\/doi.org\/10.1016\/j.parkreldis.2007.11.001","journal-title":"Parkinson Relat Disord"},{"issue":"5","key":"3229_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/mds.26535","volume":"31","author":"DM Brody","year":"2016","unstructured":"Brody DM et al (2016) Relationship between uric acid levels and progressive supranuclear palsy. Movem Disord 31(5):663\u2013667 Available at: 10.1002\/mds.26535 https:\/\/doi.org\/10.1002\/mds.26535","journal-title":"Movem Disord"},{"key":"3229_CR5","doi-asserted-by":"publisher","unstructured":"Buchinger D et al (2026) Longitudinal serum uric acid levels are not associated with dopamine transporter binding in progressive supranuclear palsy. J Neur Transm [Preprint]. Available at: https:\/\/doi.org\/10.1007\/s00702-026-03141-z","DOI":"10.1007\/s00702-026-03141-z"},{"issue":"10","key":"3229_CR6","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00415-013-7006-z","volume":"260","author":"B Cao","year":"2013","unstructured":"Cao B et al (2013) Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population. J Neurol 260(10):2511\u20132515. Available at: https:\/\/doi.org\/10.1007\/s00415-013-7006-z","journal-title":"J Neurol"},{"key":"3229_CR7","doi-asserted-by":"publisher","unstructured":"Cao B et al (2015) Association of serum uric acid level with cognitive function among patients with multiple system atrophy. J Neurol Sci 359(1\u20132):363\u2013366. Available at: https:\/\/doi.org\/10.1016\/j.jns.2015.11.025","DOI":"10.1016\/j.jns.2015.11.025"},{"issue":"9175","key":"3229_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0140-6736(98)10166-6","volume":"354","author":"D Caparros-Lefebvre","year":"1999","unstructured":"Caparros-Lefebvre D, Elbaz A (1999) Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. Lancet 354(9175):281\u2013286. Available at: https:\/\/doi.org\/10.1016\/s0140-6736(98)10166-6","journal-title":"Lancet"},{"key":"3229_CR9","doi-asserted-by":"publisher","unstructured":"Cipriani S et al (2012) Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson\u2019s disease. PloS One 7(5):e37331. Available at: https:\/\/doi.org\/10.1371\/journal.pone.0037331","DOI":"10.1371\/journal.pone.0037331"},{"issue":"4","key":"3229_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0167-4943(84)90033-5","volume":"3","author":"RG Cutler","year":"1984","unstructured":"Cutler RG (1984) Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr 3(4):321\u2013348 Available at: 10.1016\/0167-4943(84)90033-5 https:\/\/doi.org\/10.1016\/0167-4943(84)90033-5","journal-title":"Arch Gerontol Geriatr"},{"key":"3229_CR12","doi-asserted-by":"publisher","unstructured":"Cutler RG et al (2019) Uric acid enhances longevity and endurance and protects the brain against ischemia. Neurobiol Aging 75:159\u2013168. Available at: https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.10.031","DOI":"10.1016\/j.neurobiolaging.2018.10.031"},{"issue":"12","key":"3229_CR10","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1002\/mds.29222","volume":"37","author":"L Cleret de","year":"2022","unstructured":"Cleret de L et al (2022) Annonaceae consumption worsens disease severity and cognitive deficits in degenerative Parkinsonism. Movem Disord 37(12):2355\u20132366 Available at: 10.1002\/mds.29222 https:\/\/doi.org\/10.1002\/mds.29222","journal-title":"Movem Disord"},{"issue":"1","key":"3229_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ene.13412","volume":"25","author":"AB Deutschl\u00e4nder","year":"2018","unstructured":"Deutschl\u00e4nder AB et al (2018) Atypical parkinsonian syndromes: a general neurologist\u2019s perspective. Eur J Neurol 25(1):41\u201358 Available at: 10.1111\/ene.13412 https:\/\/doi.org\/10.1111\/ene.13412","journal-title":"Eur J Neurol"},{"key":"3229_CR14","doi-asserted-by":"publisher","unstructured":"Fan Z et al (2024) The association of low serum uric acid with mortality in older people is modified by kidney function: National Health and Nutrition Examination Survey (NHANES) 1999\u20132018. BMC Nephrol 25(1):108. Available at: https:\/\/doi.org\/10.1186\/s12882-024-03546-6","DOI":"10.1186\/s12882-024-03546-6"},{"key":"3229_CR15","doi-asserted-by":"publisher","unstructured":"Ga\u00ebte S et al (2021) Karubiotec\u2122 the Human Biobank of Guadeloupe (French West Indies): a driver towards Caribbean Health Research. Open J Bioresour Available at: https:\/\/doi.org\/10.5334\/ojb.75","DOI":"10.5334\/ojb.75"},{"issue":"6","key":"3229_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","volume":"86","author":"X Gao","year":"2016","unstructured":"Gao X et al (2016) Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology 86(6):520\u2013526 Available at: 10.1212\/WNL.0000000000002351 https:\/\/doi.org\/10.1212\/WNL.0000000000002351","journal-title":"Neurology"},{"key":"3229_CR17","doi-asserted-by":"publisher","unstructured":"Gong L et al (2012) Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson\u2019s disease: linking to Akt\/GSK3\u03b2 signaling pathway. J Neurochem 123(5):876\u2013885. Available at: https:\/\/doi.org\/10.1111\/jnc.12038","DOI":"10.1111\/jnc.12038"},{"key":"3229_CR18","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga F et al (2025) Protein coaggregation in caribbean atypical parkinsonism: the contribution of annonacin. Neuropathol Appl Neurobiol 51(4):e70026. Available at: https:\/\/doi.org\/10.1111\/nan.70026","DOI":"10.1111\/nan.70026"},{"key":"3229_CR19","doi-asserted-by":"publisher","unstructured":"Guerreiro S et al (2009) Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization. J Neurochem 109(4):1118\u20131128. Available at: https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06040.x","DOI":"10.1111\/j.1471-4159.2009.06040.x"},{"issue":"7","key":"3229_CR20","doi-asserted-by":"publisher","first-page":"10555","DOI":"10.18632\/aging.202820","volume":"13","author":"S-M Guo","year":"2021","unstructured":"Guo S-M et al (2021) Differential relationship of uric acid to mortality and clinical biomarkers of aging according to grip strength in older adults: a cohort study. Aging 13(7):10555\u201310583 Available at: 10.18632\/aging.202820 https:\/\/doi.org\/10.18632\/aging.202820","journal-title":"Aging"},{"issue":"4","key":"3229_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3233\/JPD-202064","volume":"10","author":"YG Hasimoglu","year":"2020","unstructured":"Hasimoglu YG et al (2020) Does serum urate change as Parkinson\u2019s disease progresses? J Parkinson\u2019s Dis 10(4):1571\u20131576 Available at: 10.3233\/JPD-202064 https:\/\/doi.org\/10.3233\/JPD-202064","journal-title":"J Parkinson\u2019s Dis"},{"issue":"4","key":"3229_CR22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.bbrc.2017.10.004","volume":"493","author":"T-T Huang","year":"2017","unstructured":"Huang T-T et al (2017) Uric acid demonstrates neuroprotective effect on Parkinson\u2019s disease mice through Nrf2-ARE signaling pathway. Biochem Biophys Res Commun 493(4):1443\u20131449. Available at: https:\/\/doi.org\/10.1016\/j.bbrc.2017.10.004","journal-title":"Biochem Biophys Res Commun"},{"key":"3229_CR23","doi-asserted-by":"publisher","unstructured":"Huang X et al (2018) Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson\u2019s disease: PALS study. Parkinsonism Relat Disord 55:50\u201354. Available at: https:\/\/doi.org\/10.1016\/j.parkreldis.2018.05.010","DOI":"10.1016\/j.parkreldis.2018.05.010"},{"key":"3229_CR24","doi-asserted-by":"publisher","unstructured":"Huertas I et al (2017) Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson\u2019s disease subtype. PloS One 12(3):e0174644. Available at: https:\/\/doi.org\/10.1371\/journal.pone.0174644","DOI":"10.1371\/journal.pone.0174644"},{"key":"3229_CR25","doi-asserted-by":"publisher","unstructured":"Kang M-G et al (2024) Higher serum uric acid as a risk factor for frailty in older adults: A nationwide population-based study. J Cachexia Sarcopenia Muscle 15(5):2134\u20132142. Available at: https:\/\/doi.org\/10.1002\/jcsm.13561","DOI":"10.1002\/jcsm.13561"},{"key":"3229_CR26","doi-asserted-by":"publisher","unstructured":"Khan AA et al (2016) Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age (Dordrecht, Netherlands) 38(1):16. Available at: https:\/\/doi.org\/10.1007\/s11357-016-9871-8","DOI":"10.1007\/s11357-016-9871-8"},{"issue":"Pt 3","key":"3229_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/brain\/awl347","volume":"130","author":"A Lannuzel","year":"2007","unstructured":"Lannuzel A et al (2007) Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain J Neurol 130(Pt 3):816\u2013827. Available at: https:\/\/doi.org\/10.1093\/brain\/awl347","journal-title":"Brain J Neurol"},{"key":"3229_CR28","doi-asserted-by":"publisher","unstructured":"Lannuzel A et al (2018) Further evidence for a distinctive atypical degenerative parkinsonism in the Caribbean: A new cluster in the French West Indian Island of Martinique. J Neurol Sci 388:214\u2013219. Available at: https:\/\/doi.org\/10.1016\/j.jns.2018.02.019","DOI":"10.1016\/j.jns.2018.02.019"},{"issue":"8","key":"3229_CR29","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/mds.23556","volume":"26","author":"JE Lee","year":"2011","unstructured":"Lee JE et al (2011) Uric acid as a potential disease modifier in patients with multiple system atrophy. Movem Disord 26(8):1533\u20131536 Available at: 10.1002\/mds.23556 https:\/\/doi.org\/10.1002\/mds.23556","journal-title":"Movem Disord"},{"key":"3229_CR30","doi-asserted-by":"publisher","unstructured":"Liu H, Reynolds GP (2025) A review of the evidence for a protective role of uric acid in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis 11(1):325. Available at: https:\/\/doi.org\/10.1038\/s41531-025-01169-8","DOI":"10.1038\/s41531-025-01169-8"},{"key":"3229_CR31","doi-asserted-by":"publisher","unstructured":"Lv H et al (2024) Associations of serum uric acid variability with neuroimaging metrics and cognitive decline: a population-based cohort study. BMC Med 22(1):256. Available at: https:\/\/doi.org\/10.1186\/s12916-024-03479-9","DOI":"10.1186\/s12916-024-03479-9"},{"issue":"1","key":"3229_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-2011-110587","volume":"27","author":"W Maetzler","year":"2011","unstructured":"Maetzler W et al (2011) Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-\u03b2 pathway. J Alzheimer\u2019s Dis JAD 27(1):119\u2013126 Available at: 10.3233\/JAD-2011-110587 https:\/\/doi.org\/10.3233\/JAD-2011-110587","journal-title":"J Alzheimer\u2019s Dis JAD"},{"issue":"4","key":"3229_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90(4):675\u2013691. Available at: https:\/\/doi.org\/10.1016\/j.neuron.2016.03.038","journal-title":"Neuron"},{"key":"3229_CR34","doi-asserted-by":"publisher","unstructured":"Moccia M et al (2015) Uric acid relates to dopamine transporter availability in Parkinson\u2019s disease. Acta Neurologica Scandinavica 131(2):127\u2013131. Available at: https:\/\/doi.org\/10.1111\/ane.12295","DOI":"10.1111\/ane.12295"},{"issue":"3","key":"3229_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/mds.26466","volume":"31","author":"JM Oropesa-Ruiz","year":"2016","unstructured":"Oropesa-Ruiz JM et al (2016) Low serum uric acid levels in progressive supranuclear palsy. Movem Disord 31(3):402\u2013405 Available at: 10.1002\/mds.26466 https:\/\/doi.org\/10.1002\/mds.26466","journal-title":"Movem Disord"},{"issue":"11","key":"3229_CR36","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","volume":"71","author":"L Pan","year":"2021","unstructured":"Pan L et al (2021) Tau in the pathophysiology of Parkinson\u2019s disease. J Mol Neurosci MN 71(11):2179\u20132191. Available at: https:\/\/doi.org\/10.1007\/s12031-020-01776-5","journal-title":"J Mol Neurosci MN"},{"key":"3229_CR37","doi-asserted-by":"publisher","unstructured":"Parkinson Study Group SURE-PD3, Investigators et al (2021) Effect of urate-elevating inosine on early parkinson disease progression: the SURE-PD3 Randomized clinical trial. JAMA 326(10):926\u2013939. Available at: https:\/\/doi.org\/10.1001\/jama.2021.10207","DOI":"10.1001\/jama.2021.10207"},{"key":"3229_CR38","doi-asserted-by":"publisher","unstructured":"Pellecchia MT et al (2016) Lower serum uric acid is associated with mild cognitive impairment in early Parkinson\u2019s disease: a 4-year follow-up study. J Neur Transm (Vienna, Austria: 1996), 123(12):1399\u20131402. Available at: https:\/\/doi.org\/10.1007\/s00702-016-1622-6","DOI":"10.1007\/s00702-016-1622-6"},{"issue":"12","key":"3229_CR39","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Movem Disord Soc 30(12):1591\u20131601 Available at: 10.1002\/mds.26424 https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Movem Disord Soc"},{"issue":"9","key":"3229_CR40","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00702-017-1743-6","volume":"124","author":"T Schirinzi","year":"2017","unstructured":"Schirinzi T et al (2017) Assessment of serum uric acid as risk factor for tauopathies. J Neur Transmiss 124(9):1105\u20131108. Available at: https:\/\/doi.org\/10.1007\/s00702-017-1743-6","journal-title":"J Neur Transmiss"},{"issue":"11","key":"3229_CR41","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/mds.29209","volume":"37","author":"F Seifar","year":"2022","unstructured":"Seifar F, Dinasarapu AR, Jinnah HA (2022) Uric acid in Parkinson\u2019s disease: what is the connection? J Movem Disord Soc 37(11):2173\u20132183 Available at: 10.1002\/mds.29209 https:\/\/doi.org\/10.1002\/mds.29209","journal-title":"J Movem Disord Soc"},{"key":"3229_CR42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.expneurol.2017.08.007","volume":"297","author":"Y-L Sheng","year":"2017","unstructured":"Sheng Y-L et al (2017) Urate promotes SNCA\/\u03b1-synuclein clearance via regulating mTOR-dependent macroautophagy. Experim Neurol 297:138\u2013147. Available at: https:\/\/doi.org\/10.1016\/j.expneurol.2017.08.007","journal-title":"Experim Neurol"},{"key":"3229_CR43","doi-asserted-by":"publisher","unstructured":"Shima S et al (2024) Uric acid and alterations of purine recycling disorders in Parkinson\u2019s disease: a cross-sectional study. NPL Parkinson\u2019s Dis 10(1):170. Available at: https:\/\/doi.org\/10.1038\/s41531-024-00785-0","DOI":"10.1038\/s41531-024-00785-0"},{"key":"3229_CR44","doi-asserted-by":"publisher","unstructured":"Shin YJ et al (2023) Uric acid regulates \u03b1-synuclein transmission in Parkinsonian models. Front Aging Neurosci 15:1117491. Available at: https:\/\/doi.org\/10.3389\/fnagi.2023.1117491","DOI":"10.3389\/fnagi.2023.1117491"},{"issue":"2","key":"3229_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3233\/JPD-181535","volume":"9","author":"I Sleeman","year":"2019","unstructured":"Sleeman I et al (2019) Urate and homocysteine: predicting motor and cognitive changes in newly diagnosed Parkinson\u2019s disease. J Parkinson\u2019s Dis 9(2):351\u2013359 Available at: 10.3233\/JPD-181535 https:\/\/doi.org\/10.3233\/JPD-181535","journal-title":"J Parkinson\u2019s Dis"},{"issue":"4","key":"3229_CR46","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/brain\/awad381","volume":"147","author":"H Tanaka","year":"2024","unstructured":"Tanaka H et al (2024) Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy. Brain J Neurol 147(4):1399\u20131411. Available at: https:\/\/doi.org\/10.1093\/brain\/awad381","journal-title":"Brain J Neurol"},{"key":"3229_CR47","doi-asserted-by":"publisher","unstructured":"Wang Z et al (2024) Seeding activity of skin misfolded tau as a biomarker for tauopathies. Mol Neurodegener 19(1):92. Available at: https:\/\/doi.org\/10.1186\/s13024-024-00781-1","DOI":"10.1186\/s13024-024-00781-1"},{"issue":"4","key":"3229_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/WCO.0b013e3283480569","volume":"24","author":"GK Wenning","year":"2011","unstructured":"Wenning GK, Krismer F, Poewe W (2011) New insights into atypical parkinsonism. Curr Opin Neurol 24(4):331\u2013338. Available at: https:\/\/doi.org\/10.1097\/WCO.0b013e3283480569","journal-title":"Curr Opin Neurol"},{"key":"3229_CR49","doi-asserted-by":"publisher","unstructured":"Yamada ES et al (2014) Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice. Experim Neurol 253:113\u2013125. Available at: https:\/\/doi.org\/10.1016\/j.expneurol.2013.12.017","DOI":"10.1016\/j.expneurol.2013.12.017"},{"key":"3229_CR50","doi-asserted-by":"publisher","unstructured":"Zang Y et al (2026) Serum metabolic markers for \u03b1-synucleinopathies conversion in isolated REM sleep behavior disorder: a prospective cohort study. Parkinsonism Relat Disord 147:108323. Available at: https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108323","DOI":"10.1016\/j.parkreldis.2026.108323"},{"key":"3229_CR51","doi-asserted-by":"publisher","unstructured":"Zhou C, Huang Y, Przedborski S (2008) Oxidative stress in Parkinson\u2019s disease: a mechanism of pathogenic and therapeutic significance. Annal N Y Acad Sci 1147:93\u2013104. Available at: https:\/\/doi.org\/10.1196\/annals.1427.023","DOI":"10.1196\/annals.1427.023"},{"key":"3229_CR52","doi-asserted-by":"publisher","unstructured":"Zhu B et al (2021) Distinct prognostic role of serum uric acid levels for predicting all-cause mortality among Chinese adults aged 45\u2009\u201375 years with and without diabetes. Fronti Endocrinol 12:782230. Available at: https:\/\/doi.org\/10.3389\/fendo.2021.782230","DOI":"10.3389\/fendo.2021.782230"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03229-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:19:35Z","timestamp":1792577975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03229-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3229"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03229-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No conflicting relationship exists for the authors.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}